Cargando…
Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
Adoptive cell therapy (ACT) with tumor-infiltrating T cells (TILs) has emerged as a promising therapy for the treatment of unresectable or metastatic solid tumors. One challenge to finding a universal anticancer treatment is the heterogeneity present between different tumors as a result of genetic i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067276/ https://www.ncbi.nlm.nih.gov/pubmed/33916369 http://dx.doi.org/10.3390/cells10040808 |